Craft

Reneuron Group

Stock Price

£0

2024-08-30

Market Capitalization

£1.9 M

2024-08-30

Revenue

£849 K

FY, 2025

Reneuron Group Summary

Company Summary

Overview
ReNeuron is a leading, UK-based stem cell company. Our primary objective is the development of stem cell therapies targeting areas of significant unmet or poorly met medical need
Type
Public
Status
Active
Founded
1997
HQ
Pencoed, GB | view all locations
Website
http://www.reneuron.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Iain Ross

    Iain Ross, Executive Chairman

    • John Hawkins

      John Hawkins, Chief Financial Officer and Director

    • Randolph Corteling

      Randolph Corteling, Chief Scientific Officer

    • Suzanne Hancock

      Suzanne Hancock, Chief Operations Officer

    LocationsView all

    1 location detected

    • Pencoed, Wales HQ

      United Kingdom

    Reneuron Group Financials

    Summary Financials

    Revenue (FY, 2025)
    £849.0K
    Gross profit (FY, 2025)
    £849.0K
    Net income (FY, 2025)
    £782.0K
    Cash (FY, 2025)
    £513.0K
    EBIT (FY, 2025)
    £734.0K

    Footer menu